We previously reported RE2 (anti-pan MHC class I) and 4713 (anti-pan HLA class II) monoclonal antibodies that induce complement-, ADCC-, and ADCP-independent direct cell death in malignant lymphoma cells. This evidence concerns the gene GPR161 and lymphoma.